HYPE3.SA

Hypera S.A. [HYPE3.SA] Stock Forecast

Q: What is Hypera S.A. stock symbol ?

Hypera S.A. is a BR stock, located in São paulo of Sp and trading under the symbol HYPE3.SA

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

HYPE3.SA Stock Summary

Earnings have grown 27.1% per last year.

Earnings are expected to rise 35.96% next year

EPS has been increasing for the past 3 years (Yearly statements)

HYPE3.SA's dividend payments are well covered by cash flows with cash payout ratio of 43.99%.

HYPE3.SA has more than 4401 years of cash runway (52819 months)

HYPE3.SA's dividend payments have fallen since the beginning of the year

Top 10 Correlated ETFs

HYPE3.SA

Top 10 Correlated Stocks

HYPE3.SA

In the News

HYPE3.SA Financial details

Company Rating

Strong Buy

Market Cap

21.7B

Income

1.77B

Revenue

8.19B

Book val./share

Cash/share

3.02

Dividend

1.23

Dividend %

3.67%

Employees

Optionable

Shortable

Yes

Earnings

14 Feb 2024

P/E

Forward P/E

9.9

PEG

3.67

P/S

2.59

P/B

1.86

P/C

11.11

P/FCF

17.02

Quick Ratio

1.24

Current Ratio

1.89

Debt / Equity

0.87

LT Debt / Equity

0.7

EPS (TTM)

2.8

EPS next Y

3.39

EPS next Q

0.84

EPS this Y

27.49%

EPS next Y

21.14%

EPS next 5Y

41.81%

EPS last 5Y

8.49%

Revenue last 5Y

15.17%

Revenue Q/Q

-4.15%

EPS Q/Q

SMA20

3.11%

SMA50

-12.93%

SMA100

-24.28%

Inst Own

Inst Trans

ROA

ROE

16%

ROC

0.14%

Gross Margin

63%

Oper. Margin

35%

Profit Margin

22%

Payout

44%

Shs Outstand

632.65M

Shs Float

371.46M

Target Price

52W Range

29.61-47.02

52W High

-28.62%

52W Low

+15.69%

RSI

48.64

Rel Volume

1.94

Avg Volume

3.48M

Volume

6.74M

Perf Week

-1.18%

Perf Month

-1.44%

Perf Quarter

-24.22%

Perf Half Y

-19.02%

Beta

0.318

Volatility

0.47%, 1.34%

Prev Close

0.42%

Price

33.55

Change

-1.64%

HYPE3.SA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	5.89	5.22	6.48	9.4	11.94
Net income per share	1.79	1.84	2.05	2.1	2.68
Operating cash flow per share	1.69	1.31	1.87	2.21	3.22
Free cash flow per share	1.34	0.73	-1.18	0.89	0.84
Cash per share	2.27	2.27	6.19	2.8	4.53
Book value per share	13.08	13.8	14.64	15.55	16.84
Tangible book value per share	5.39	5.98	4.5	-0.26	-0.7
Share holders equity per share	13.08	13.8	14.64	15.55	16.84
Interest debt per share	0.99	2.3	9.13	12.33	16.87
Market cap	19.69B	22.53B	21.62B	17.87B	27.65B
Enterprise value	18.62B	21.69B	22.47B	22.99B	34.47B
P/E ratio	17.43	19.36	16.7	13.43	16.29
Price to sales ratio	5.29	6.84	5.29	3.01	3.66
POCF ratio	18.46	27.35	18.28	12.77	13.56
PFCF ratio	23.28	48.74	-29.06	31.89	52.23
P/B Ratio	2.38	2.59	2.34	1.82	2.6
PTB ratio	2.38	2.59	2.34	1.82	2.6
EV to sales	5	6.58	5.5	3.87	4.57
Enterprise value over EBITDA	13.57	17.09	14.79	10.59	12.26
EV to operating cash flow	17.46	26.33	19	16.43	16.9
EV to free cash flow	22.02	46.93	-30.2	41.03	65.11
Earnings yield	0.06	0.05	0.06	0.07	0.06
Free cash flow yield	0.04	0.02	-0.03	0.03	0.02
Debt to equity	0.07	0.16	0.61	0.75	0.91
Debt to assets	0.06	0.12	0.32	0.37	0.41
Net debt to EBITDA	-0.78	-0.66	0.56	2.36	2.43
Current ratio	3.04	2.99	3.01	2.34	1.63
Interest coverage	26.6	25.12	7.94	5.31	2.68
Income quality	0.87	0.78	0.98	1.16	1.28
Dividend Yield	0.03	0.03	0.03	0.04	0.03
Payout ratio	0.56	0.54	0.53	0.56	0.48
Sales general and administrative to revenue	0.01	0.01	0.01	0.01	0.01
Research and developement to revenue	0.02	0.04	0.04	0.02	0.02
Intangibles to total assets	0.46	0.41	0.37	0.5	0.47
Capex to operating cash flow	-0.21	-0.44	-1.63	-0.6	-0.74
Capex to revenue	-0.06	-0.11	-0.47	-0.14	-0.2
Capex to depreciation	-2.48	-3	-15.86	-6.28	-8.93
Stock based compensation to revenue	0.01	0.01	0	0	0
Graham number	22.94	23.93	25.99	27.14	31.89
ROIC	0.13	0.12	0.1	0.12	0.14
Return on tangible assets	0.2	0.17	0.12	0.14	0.13
Graham Net	1.26	-0.36	-3.47	-8.8	-10.8
Working capital	2.9B	3.15B	5.27B	3.72B	3.3B
Tangible asset value	3.41B	3.77B	2.84B	-163.69M	-440.03M
Net current asset value	2.03B	1.53B	-109.93M	-3.49B	-4.57B
Invested capital	0.07	0.16	0.61	0.75	0.91
Average receivables	1.7B	1.71B	1.77B	2.3B	2.87B
Average payables	330.95M	408.58M	713.1M	879.55M	1.05B
Average inventory	525.73M	630.66M	792.72M	1.11B	1.75B
Days sales outstanding	176.81	179.39	172.13	164.06	149
Days payables outstanding	123.84	138.22	242.15	135.22	171.65
Days of inventory on hand	205.65	200.65	230.26	222.9	287.82
Receivables turnover	2.06	2.03	2.12	2.22	2.45
Payables turnover	2.95	2.64	1.51	2.7	2.13
Inventory turnover	1.77	1.82	1.59	1.64	1.27
ROE	0.14	0.13	0.14	0.14	0.16
Capex per share	-0.35	-0.57	-3.05	-1.33	-2.39

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	3.21	3.35	2.69	3.52	3.38
Net income per share	0.73	0.68	0.54	0.79	0.79
Operating cash flow per share	1.07	0.81	0.48	0.91	1.15
Free cash flow per share	0.71	0.39	0.15	0.57	0.86
Cash per share	3.5	4.52	1.72	2.89	3.02
Book value per share	16.56	16.81	17.09	17.44	18
Tangible book value per share	16.58	-0.69	-0.6	-0.38	0.05
Share holders equity per share	16.56	16.81	17.09	17.44	18
Interest debt per share	14.45	15.74	14.39	16.01	16.07
Market cap	28.03B	27.7B	23.83B	29.15B	23.49B
Enterprise value	34.7B	34.52B	31.55B	36.86B	31.15B
P/E ratio	15.06	16.18	17.61	14.48	11.76
Price to sales ratio	13.77	13.06	14.03	13.06	10.99
POCF ratio	41.37	53.84	79.05	50.42	32.43
PFCF ratio	61.93	113.27	245.74	80.19	43.32
P/B Ratio	2.67	2.6	2.21	2.64	2.06
PTB ratio	2.67	2.6	2.21	2.64	2.06
EV to sales	17.04	16.27	18.58	16.52	14.56
Enterprise value over EBITDA	45.42	43.75	50.57	44.73	37.15
EV to operating cash flow	51.21	67.1	104.65	63.77	43
EV to free cash flow	76.67	141.15	325.32	101.42	57.43
Earnings yield	0.02	0.02	0.01	0.02	0.02
Free cash flow yield	0.02	0.01	0	0.01	0.02
Debt to equity	0.85	0.91	0.81	0.89	0.87
Debt to assets	0.39	0.41	0.39	0.41	0.41
Net debt to EBITDA	8.73	8.64	12.37	9.36	9.13
Current ratio	1.81	1.63	1.96	1.96	1.89
Interest coverage	2.72	2.53	1.97	2.69	2.61
Income quality	1.55	1.18	1.12	1.23	1.53
Dividend Yield	0	0	0.03	0	0
Payout ratio	0.05	0.12	2	0.05	0.06
Sales general and administrative to revenue	0.01	0.01	0.01	0.01	0.01
Research and developement to revenue	0.01	0.03	0.02	0.02	0.02
Intangibles to total assets	0.49	0.47	0.5	0.47	0.47
Capex to operating cash flow	-0.33	-0.52	-0.68	-0.37	-0.25
Capex to revenue	-0.11	-0.13	-0.12	-0.1	-0.09
Capex to depreciation	-5.21	-5.5	-3.95	-3.8	-2.97
Stock based compensation to revenue	0	0	0	0	0.01
Graham number	16.55	15.98	14.35	17.65	17.88
ROIC	0.04	0.04	0.04	0.04	0.04
Return on tangible assets	0.04	0.03	0.03	0.04	0.04
Graham Net	-10.56	-10.78	-11.5	-11.62	-11.54
Working capital	3.35B	3.3B	3.38B	3.91B	3.82B
Tangible asset value	-516.7M	-440.03M	-381.53M	-242.18M	33.93M
Net current asset value	-4.56B	-4.57B	-4.79B	-4.75B	-4.77B
Invested capital	0.85	0.91	0.81	0.89	0.87
Average receivables	2.8B	2.96B	2.97B	3.04B	3.31B
Average payables	1.08B	1.25B	1.28B	1.16B	1.01B
Average inventory	1.86B	2.1B	2.3B	2.35B	2.25B
Days sales outstanding	125.95	130.69	151.81	129.59	143.66
Days payables outstanding	142.93	147.44	183.57	117.37	109.77
Days of inventory on hand	243.26	247.22	352.08	252.12	253.17
Receivables turnover	0.71	0.69	0.59	0.69	0.63
Payables turnover	0.63	0.61	0.49	0.77	0.82
Inventory turnover	0.37	0.36	0.26	0.36	0.36
ROE	0.04	0.04	0.03	0.05	0.04
Capex per share	-0.36	-0.43	-0.32	-0.34	-0.29

HYPE3.SA Dividend History

HYPE3.SA Frequently Asked Questions

What is Hypera S.A. stock symbol ?

Hypera S.A. is a BR stock , located in São paulo of Sp and trading under the symbol HYPE3.SA

What is Hypera S.A. stock quote today ?

Hypera S.A. stock price is $33.55 today.

Is Hypera S.A. stock public?

Yes, Hypera S.A. is a publicly traded company.

Something similar

Top by Market Cap

M&M.NS

Company Profile

Volume Average 3.48M
Market Capitalization 21.7B
Employee 9K
CEO Mr. Breno Toledo Pires de Oliveira
Headquarters São Paulo,SP,BR
IPO Date 2008-04-18
Website https://www.hyperapharma.com.br

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.